Currently holds a position at Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Syndax Pharmaceuticals Inc | Jan. 4, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-13 | 2023-01-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
5,000
-13.5%
27.00135,000 USD |
5,000 -13.5% | 27.00 | 135,000 USD | |
2023-01-13 | 2023-01-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
10,000
-23.8%
27.00270,000 USD |
10,000 -23.8% | 27.00 | 270,000 USD | |
2023-01-13 | 2023-01-12 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
24,000
-42.9%
26.74641,782 USD |
24,000 -42.9% | 26.74 | 641,782 USD | |
2022-08-09 | 2022-08-05 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
14,000
-30.4%
23.02322,223 USD |
14,000 -30.4% | 23.02 | 322,223 USD | |
2022-08-09 | 2022-08-05 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
10,000
-23.8%
23.02230,159 USD |
10,000 -23.8% | 23.02 | 230,159 USD | |
2021-12-22 | 2021-12-22 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
97,860
-100.0%
58.015,676,859 USD |
97,860 -100.0% | 58.01 | 5,676,859 USD | |
2021-12-22 | 2021-12-22 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
24,000
-60.0%
22.01528,206 USD |
24,000 -60.0% | 22.01 | 528,206 USD | |
2021-12-22 | 2021-12-21 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
44,537
-100.0%
57.112,543,508 USD |
44,537 -100.0% | 57.11 | 2,543,508 USD | |
2021-12-22 | 2021-12-20 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
7,603
-100.0%
57.02433,523 USD |
7,603 -100.0% | 57.02 | 433,523 USD | |
2021-12-22 | 2021-12-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
20,000
-55.6%
21.01420,250 USD |
20,000 -55.6% | 21.01 | 420,250 USD | |
2021-04-09 | 2021-04-08 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
239
-100.0%
32.137,679 USD |
239 -100.0% | 32.13 | 7,679 USD | |
2021-04-09 | 2021-04-08 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
12,099
-98.1%
31.40379,909 USD |
12,099 -98.1% | 31.40 | 379,909 USD | |
2021-04-09 | 2021-04-08 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
12,500
-50.3%
32.00400,000 USD |
12,500 -50.3% | 32.00 | 400,000 USD | |
2021-04-02 | 2021-03-31 |
Bicycle Therapeutics PLC
(BCYC)
|
PS Planned sale |
10,000
-100.0%
30.00300,000 USD |
10,000 -100.0% | 30.00 | 300,000 USD | |
2021-03-19 | 2021-03-17 |
Bicycle Therapeutics PLC
(BCYC)
|
S Sale |
7,784
-100.0%
29.00225,736 USD |
7,784 -100.0% | 29.00 | 225,736 USD | |
2021-03-16 | 2021-03-12 |
Bicycle Therapeutics PLC
(BCYC)
|
S Sale |
2,216
-100.0%
29.0064,264 USD |
2,216 -100.0% | 29.00 | 64,264 USD |